VISION IMPAIRMENT IN CHILDREN AND THE IMPACT ON CHILDREN AND THEIR FAMILIES
With
Dr Susan Silveira
Chief Investigator
Australian Childhood Vision Impairment Register, NextSense &
Program Director
Master of Disability Studies (Macquarie University),
NextSense, Sydney, Australia
RESEARCHER PROFILE
Filmed in Sydney | June 2025
Sue is a qualified paediatric orthoptist who has held both clinical and academic roles. She has a Master of Health Sciences (Education) from the University of Sydney, and a PhD from the University of Newcastle.
Sue holds a conjoint academic position with Macquarie University and is the Course Director for their Master of Disability Studies, which is administered and delivered by NextSense Institute in affiliation with the University. She teaches in the areas of vision impairment and disability, and aims to share her knowledge while learning from others, especially people who are blind or have low vision and their families.
A research fellow with NextSense Institute, Sue is the chief investigator on a collaborative partnership project that established the Australian Childhood Vision Impairment Register, which captures data to help improve services for children who are blind or have low vision. She is also a co-investigator on a project that aims to raise awareness about when and why braille should be introduced in a child’s life, and is working as part of a research team developing accessible playgrounds.
Sue has worked extensively in the NSW public hospital system and in vision screening programs, and has held an academic position with the University of Sydney’s School of Orthoptics, in addition to working at The Children’s Hospital at Westmead—the largest paediatric centre in NSW.
Through her research, Sue aims to give a voice to people who are blind or have low vision, and to broadly improve their quality of life.
Outside of work, she prioritises her family and tries to spend time on her loved pastime–drawing.
Source: Supplied
-
Better biomarkers for predicting the incidence of having atherosclerosis and heart attack
Assoc Prof Bursill is a vascular biologist with interests and expertise in vascular inflammation, atherosclerosis and angiogenesis. She completed her PhD at The University of Adelaide in lipid metabolism then headed to Oxford University for five years to undergo a postdoctoral post in the Departments of Cardiovascular Medicine and Pathology. Her postdoctoral time triggered her interest in the mechanisms that cause atherosclerosis and in particular the role of small inflammatory proteins called chemokines.
-
Causal genes and pathogenic mechanisms underlying gastrointestinal diseases
Professor D’Amato has more than 25 years research experience in the field of human genetics and complex diseases, with activities most recently geared towards a translational application for therapeutic precision in gastroenterology. His team, the Gastrointestinal Genetics Laboratory, combine leading expertise in genomic, computational and pre-clinical research, and have contributed important breakthroughs linking specific genes and pathogenetic mechanisms to a number of gastrointestinal diseases like inflammatory bowel disease (IBD), microscopic colitis (MC) and irritable bowel syndrome (IBS).
-
Identification, characterisation and role of leader cells in ovarian cancer progression
Dr. Maree Bilandzic is a molecular cancer biologist dedicated to advancing the understanding and treatment of ovarian cancer (OC). Her research addresses critical gaps in OC treatment by investigating the mechanisms behind metastasis, chemotherapy resistance, and tumour recurrence. By utilising innovative methodologies and disease-representative models, Dr. Bilandzic has pioneered the identification and characterisation of leader cells (LCs)—a unique, stem-like subpopulation within tumours that plays a crucial role in OC progression.
